Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials-Reference-Cited by-同舟云学术

Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials

Published:2017-03-22 Issue:10 Volume:45 Page:1291-1302
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Cholapranee A.¹,Hazlewood G. S²³,Kaplan G. G.²,Peyrin-Biroulet L.⁴,Ananthakrishnan A. N.⁵^ORCID

Affiliation:

1. Department of Internal Medicine; Montefiore Medical Center; New York NY USA

2. Departments of Medicine and Community Health Sciences; University of Calgary; Calgary AB Canada

3. McCaig Institute for Bone and Joint Health; University of Calgary; Calgary AB Canada

4. Inserm U954 and Department of Gastroenterology; Nancy University Hospital; Université de Lorraine; Vandoeuvre France

5. Gastroenterology Unit; Massachusetts General Hospital; and Harvard Medical School; Boston MA USA

Funder

UCB Pharma

Abbott

Canadian Institutes of Health Research

Janssen

AbbVie

National Institutes of Health

Merck

Amgen

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14030/fullpdf

Reference54 articles.

1. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

2. The burden of inflammatory bowel disease in Europe;Burisch;J Crohns Colitis,2013

3. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis;Ananthakrishnan;Inflamm Bowel Dis,2013

4. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort;Froslie;Gastroenterology,2007

5. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?;Rutgeerts;Gut,2007

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

4. Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients;Inflammopharmacology;2024-07-10

5. Recomendaciones basadas en el manejo de pacientes con diagnóstico de enfermedad de Crohn en el contexto peruano. Documento de posición de la Asociación Peruana para el Estudio del Intestino (ASPEIN);Revista de Gastroenterología del Perú;2024-06-26